Using CURES to combat prescription drug abuse/misuse

Similar documents
April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

Prescription Drug Monitoring Program

Prescription Drug Abuse Task Force Rx Report Card

Opioid Focus Group Summaries

Prescription Drug Abuse and Heroin: Impact on Oregon s Youth and Young Adults

Michigan Automated Prescription System

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update

D. Todd Bess, PharmD 1

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

Curbing Prescription Drug Abuse in Medicaid

Strategies for Managing Your Medications

Protecting Children s Safety: How Prescription Drug Monitoring Programs Can Assist An Update Presenter: John L. Eadie Moderator: Cindy Rodgers

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

PRESCRIPTION DRUG ABUSE

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES

California. Prescribing and Dispensing Profile. Research current through November 2015.

State of California Department of Justice. Bureau of Narcotic Enforcement

The Role of the PDMP: Foundational Knowledge and Best Practices

The Impact of the U.S. Drug Enforcement Agency Schedule Changes for Hydrocodone and Tramadol on California Prescriptions Patterns

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment

Prescription Drugs MODULE 5 ALLIED TRADES ASSISTANCE PROGRAM. Preventative Education: Substance Use Disorder

Opioids drive continued increase in drug overdose deaths

PRESCRIBING GUIDELINES

Prescription Drug Abuse National Perspective

4/3/2018. The Role of Pharmacists in the Safe Prescribing of Opioids: Having the Tough Talks with Patients and Prescribers. Learning Objectives

National Council on Patient Information and Education

Managing Narcotics on Workers Comp Claims. Presented By: Craig S. Stern, PharmD, MBA President Pro Pharma Pharmaceutical Consultants, Inc.

Arkansas Department of Health

Questions and answers about HCA s opioid clinical policy for Apple Health (Medicaid)

Risk Reduction Strategies in Pain Management

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Opioid Use and Other Trends

New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers

C U S T O M E R D R I V E N. B U S I N E S S M I N D E D.

INFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People

Law Enforcement and the Prescriber Enforcement Action Protocol

Resist the Opioid Pendulum: Understanding Opioids and Pain, and how they relate to Addiction

Tracker e-prescribing 101. The Complete Guide

Technician Training Tutorial: Safety Considerations with Opioids

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.

Prescription Drug Safety for Teens

Pennsylvania Prescription Drug Monitoring Program Trends,

PHARMACY Section 9. Overview. Preferred Drug List. Additions and Exceptions to the Preferred Drug List

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Evaluation of the N.C. Prescription

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Managed Care Pushes for Safer Opioid Oversight

Top 10 narcotic pain pills

Substance Use Trends in the Military, Veteran and Family Population

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

they will need higher doses to get good pain relief.

Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases

Teens Living with Epilepsy

View/Enter Patient Record. 3.1 CP-UC1-PS1 Refill Prescription (CASH)

& CONSUMES 80% 5% OF THE WORLD S POPULATION 5/19/2017. New Naloxone Regulations & the Importance of Using PRESCRIPTION DRUG ABUSE EPIDEMIC

Prescription Monitoring Program (PMP)

Barbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County

WILLIAMS, WYCKOFF & OSTRANDER, PLLC Attorneys at Law

Presentation Objectives

PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998

OLDER ADULT TOOLKIT Trivia Game Facilitator s Guide

Outline. Decreasing total opioid prescriptions Decreasing benzodiazepine and opioid co-prescription. Increasing community awareness of opioid risks

Teaching Objectives Describe the balance a that must be sought in the treatment of pain and the prevention of drug diversion. Discuss regulatory polic

Preventing Rx Abuse in Your Community

SleepImage Website Instructions for Use

Anyone Can Become Addicted. Anyone.

Mingo County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

Putnam County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017

Patient Agreement for the use of Opioid Medications

Do not open the test booklet prior to being told to do so.

SCRIPTS. South Carolina Reporting & Identification Prescription Tracking System

Pain Notebook NAME PHONE. Three Hole Punch Here Three Hole Punch Here. Global Pain Initiative 2018 Ver 1.0

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)

SAFE OPIOID PRESCRIBING C.U.R.E.S. PROGRAM

REB CLOSE, MD Community Hospital of the Monterey Peninsula

Popping Pills for Thrills Implications for preventing the misuse of pharmaceuticals

Oxycodone assistance program

Pocahontas County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

Controlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System

Drug Prevention: Health & Opioid Prevention Education (HOPE) Curriculum

Kanawha County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION

Wellness along the Cancer Journey: Palliative Care Revised October 2015

Medicare Part D Opioid Policies for 2019 Information for Patients

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Nebraska: What s Going On with the PDMP and HIE

Taking Opioids Responsibly for Your Safety and the Safety of Others: Patient Information Guide on Long-term Opioid Therapy for Chronic Pain

University of Alaska Connected! FAQs

Best Practices and Foundation Forum. Fred Wells Brason II

The Opioid Epidemic and How It is Impacting the Workplace. July 24, 2018

Transcription:

Using CURES to combat prescription drug abuse/misuse Speakers Nathan Painter PharmD, CDE Email: npainter@ucsd.edu Rabia Atayee, PharmD, BCPS Email: ratayee@ucsd.edu UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences Objectives Identify prescription drug abuse issues that impact pharmacists practice Identify red flags of aberrant drug behavior Describe CURES 2.0 and its updated features 1

Epidemiology of Prescription Drug Misuse and Abuse National Nearly 1 in 5 teens have used prescription drugs to get high. 7 of the top 10 drugs abused by 12 th graders are prescription drugs or OTC medications. California Prescription drug use is accelerating Prescription drug use exceed all other drugs other than marijuana Deaths involving opioid prescription medications have increased 16.5 percent since 2006. In 2012, there were more than 1,800 deaths from all types of opioids 72 percent involved prescription opioids Epidemiology of Prescription Drug Misuse and Abuse public health concern for age 18-25 group In 1999, roughly 4000 people were killed by an overdose of prescription opioid -> in 2008, increased to nearly 15,000 people Increased Emergency Department (ED) visits by 150% in 18-20 year-old group and 24.5% in 21-24 year-old age group 2

Prescription Drug Overdose MMWR. 1/2012. 61(1). http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6101a3.htm?s_cid=mm6101a3_w Prescription Drug Overdose Prescription Drug Overdose 3

Epidemiology of Prescription Drug Misuse and Abuse Broad availability of prescription drugs and misperceptions about their safety make prescription medications particularly prone to abuse Among those who abuse prescription drugs, high rates of other risky behaviors, including abuse of other drugs and alcohol, have also been reported Substance Abuse and Mental Health Services Administration Survey 2009-2010 The homes of relatives or friends as key sources for people to start misusing powerful painkillers Drugs left in home medicine cabinets are prime targets for prescription drug abuse Among first-time or occasional users of prescription pain killers, most received them from family or friends Among chronic abusers of pain relievers, 41% obtained pills for free or without asking from friends or relatives 26% got a prescription 4

Unmet Need Only 29% of pharmacists strongly agreed that their knowledge of relevant controlled-substance regulation was adequate Pharmacists and physicians believe that there are gaps in their education with respect to drug abuse > 67% of pharmacists reported that they received 2 hours or less of addiction and substance abuse education in pharmacy school Almost 30% received no addiction education Many pharmacists are also unaware of the important distinctions among addiction, physical dependence, and tolerance. >50% had never referred a patient to a drug treatment program. Joranson DE, Gilson AM. Pharmacists knowledge of and attitudes toward opioid pain medications in relation to federal and state policies. J Am Pharm Assoc. 2001;41:213-220. Lafferty L, Hunter TS, Marsh WA. Knowledge, attitudes and practices of pharmacists concerning prescription drug abuse. J Psychoactive Drug. 2006;38:229-232. Corresponding Responsibility Pharmacist must evaluate patients to ensure the appropriateness of any controlled substance prescription California Board of Pharmacy: If a pharmacist believes that a prescription may not have been written for a legitimate medical purpose, the pharmacist must inquire When the results of a reasonable inquiry do not overcome the pharmacist's concern about a prescription being written for a legitimate medical purpose, the pharmacist must not fill the prescription. http://www.pharmacy.ca.gov/consumers/rx_abuse_prevention.shtml Legitimate Medical Purpose A prescriber s prescription pattern is different from that of other prescribers in the area Prescriber writes for antagonistic drugs A number of people appear within a short time period for the same controlled drug from the same physician A large number of previously unknown patrons show up with prescriptions from the same physician The patron presents a prescription that shows evidence of possible forgery DEA. Pharmacist s Manual: An Information Outline of the Controlled Substances Act of 1970. Washington, DC: DEA; April 2004. 5

Red Flags Board of Pharmacy Irregularities on the face of the prescription itself Nervous patient demeanor Age or presentation of patient Multiple patients at the same address Multiple prescribers for the same patient for duplicate therapy Cash payments http://www.pharmacy.ca.gov/consumers/rx_abuse_prevention.shtml Red Flags Board of Pharmacy Requests for early refills of prescriptions Prescriptions written for an unusually large quantity of drugs Prescriptions written for duplicative drugs Initial prescriptions written for stronger opiates Long distances traveled from the patient's home to the prescriber's office or pharmacy http://www.pharmacy.ca.gov/consumers/rx_abuse_prevention.shtml Red Flags Board of Pharmacy Irregularities in the prescriber's qualifications in relation to the medication(s) prescribed Prescriptions that are written outside of the prescriber's medical specialty Prescriptions for medications with no logical connection to diagnosis or treatment http://www.pharmacy.ca.gov/consumers/rx_abuse_prevention.shtml 6

Case 1 RA is a 25 yo female that comes to your pharmacy. She presents 3 different written prescriptions from 3 different prescribers. Percocet 5/325, Ultram 50 mg, Valium 5 mg It is the first time she has come to your pharmacy and she presents her insurance information. As you are obtaining her address and phone number you realize her home is about 2 hours from your pharmacy. As you run the prescriptions the insurance system flags that all 3 prescription are too early (14, 7, 3 days early). Sometimes my roommates borrow my medications. Don t worry, I will just pay cash for them. My back is really killing me. How does a pharmacist find balance? Identify red flags Establish workflow to allow time to resolve red flags Document all your interventions Remember first, do no harm 20 Case 1-RED FLAGS RA is a 25 yo female that comes to your pharmacy. She presents 3 different written prescriptions from 3 different prescribers. Percocet 5/325, Ultram 50 mg, Valium 5 mg It is the first time she has come to your pharmacy and she presents her insurance information. As you are obtaining her address and phone number you realize her home is about 2 hours from your pharmacy. As you run the prescriptions the insurance system flags that all 3 prescription are too early (14, 7, 3 days early). Sometimes my roommates borrow my medications. Don t worry, I will just pay cash for them. My back is really killing me. 21 7

Case 1 continued You check CURES and notice that she has paid cash 4 other times in the last 6 months for these same medications. You call all 3 prescribers and leave a message to call back. It s Sunday and you don t not anticipate anyone will call you back. 22 WHAT WOULD YOU DO? Communication Self confidence to: detect RX abuse discuss RX abuse with patients discuss legitimacy of controlled RX with prescriber 25% pharmacist fear damaging pharmacistprescriber relationship Communication between the pharmacist and provider would serve to deter prescription drug abuse Hagemeier NE, et al. Prescription Drug Abuse: A Comparison of Prescriber and Pharmacist Perspectives. Subst Use Misuse. 2013 Jun;48(9):761-8 8

CURES 2.0 CURES 2.0: Updated Features Dashboard: Potential for communication with other prescribers Notifying prescribers of 5 categories of alerts Ability to save previous patient search 2 different options for view results CURES 2.0: Updated Features CURES reports will provide additional information including Date sold Presence of a pain contract with a provider Payment method Assign a delegate to upload CURES reports Allow inclusion of CURES reports in patient records 9

https://oag.ca.gov/cures CURES Registration Update User Profile required at first use The first time you enter the site you will be asked to enter your user profile information Select the phone number and email that you want used by other providers who may want to reach you Update your profile whenever you like by clicking User Profile on home screen NEW PASSWORD. You will be required to update to a new password every 6 months or every time you forget your password 30 10

Searching https://cures.doj.ca.gov User name is often first 2 letter of first name followed by last name 31 Manage Saved Searches Enter Search Criteria Only 3 mandatory entries Last Name First Name Date of Birth You can further specify additional criteria You can scroll to your SAVED SEARCH 33 11

Select and View Details Jane Doe To SELECT ALL Click on top box Save Search (if you want) Click View Details for results 34 View Results Options Select How You want to View Results Download PAR = Excel File that allows modification to file and you can save work Print PAR = Formatted Style that you can print or save (more clinically friendly version) 35 Date filled versus Date sold Presence of a compact or a pain contract Download PAR 12

Payment method Print PAR ALERTS Don t be alarmed, chances are that if you see lot of patients you will have alerts. Click on the number in black box to find out cause for alert. There are 5 categories of alerts. 1. > 100 MED per day 2. Obtain >6 providers or > 6 pharmacies in 6 months 3. > 40 mg/ day methadone 4. Opioids > 90 consecutive days 5. Opioid + Benzodiazepines 13

Data Accuracy The data is only as accurate as what pharmacies upload to CURES Pharmacies are required by law to upload data within 7 days (but may be longer ) Some load within 24 hours, others take 7 days. CURES enters the pharmacy data into the system within 4 hours The VA and Military pharmacies are not required to enter data into CURES If you notice a data discrepancy, only the pharmacy can make a change (CURES office will not change the data) CASE 2 JS comes into the pharmacy for the first time and drops off a prescription for hydromorphone 2 mg tablets to take PO q6h prn pain qty 120. Your technician processes the prescription and was able to obtain JS s medication allergy, insurance information along with phone number and home address. The medication goes through on the insurance. JS says I will come back later today to pick up the prescription. When you review the filled prescription you notice, JS s home address is about 200 miles away from our pharmacy. Your technician tells you that I noticed that JS looked worried and tired. How would you proceed? 14

CASE 2 continued Check CURES CASE 2 Summary This case example shows that the pharmacist correctly observed a red flag, and by calling the provider the concern over the red flag was resolved. Pharmacists should not interpret a red flag as automatically mean not filling a prescription. A red flag means that the prescription should be checked. Delegate Feature You can assign a delegate(s) to upload CURES reports for you. The delegate can enter the data and save the search. However, the delegate cannot access the actual report. You must enter the system access data under Saved Search. You can add up to 50 delegates You can delete delegates CURES will automatically delete delegates with no provider use (aka parent) for 30 days or no log in for 12 months 45 15

Manage Delegate The delegate is your office manager, nurse, or assigned Complete all 4 boxes and click Add other assigned person 46 Documentation Each institution is advised to include CURES in the medical documentation Print PAR, place patient sticker, and add to medical record In EMR, find a uniform place to file CURES OR Dictate CURES results in medical records: No aberrant drug seeking behaviors identified in CURES CURES showed regular opioids by single physician CURES showed last Rx for hydrocodone #60 on 1/1/16 When CURES unavailable, document CURES system down Locked out of account CURES Website Resources Main web page is at https://oag.ca.gov/cures Informational publications and tutorial videos https://oag.ca.gov/cures/publications FAQs at https://oag.ca.gov/cures/faqs 16

Conclusion Prescription drug abuse/misuse is a significant public health issue Pharmacists have an ethical duty, backed by both federal and state law, to ensure that a prescription for a controlled substance is appropriate Pharmacist have the tools to be part of the solution Thank You! Speaker Contact Information: Nathan Painter PharmD, CDE Email: npainter@ucsd.edu Rabia Atayee, PharmD, BCPS Email: ratayee@ucsd.edu UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences 17